A new neurological focus in neonatal intensive care

Nature Reviews Neurology

Volumn 7, Issue 9, 2011, Pages 485-494

  Bonifacio, Sonia L ^a   Glass, Hannah C ^a   Peloquin, Susan ^a   Ferriero, Donna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTICONVULSIVE AGENT; ANTIOXIDANT; ERYTHROPOIETIN; ETIRACETAM; MELATONIN; PHENOBARBITAL; TOPIRAMATE; XENON;

ANEMIA; BRAIN INJURY; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG MECHANISM; ECHOGRAPHY; ELECTROENCEPHALOGRAM; EVIDENCE BASED PRACTICE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INFECTION PREVENTION; NEONATAL FOCAL ISCHEMIC STROKE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROMONITORING; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NEWBORN INTENSIVE CARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PARTICIPATORY MANAGEMENT; PEDIATRIC NURSING; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE;

ANESTHETICS, INHALATION; ANTICONVULSANTS; ANTIOXIDANTS; ASPHYXIA NEONATORUM; ELECTROENCEPHALOGRAPHY; ERYTHROPOIETIN; HUMANS; HYPOTHERMIA, INDUCED; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MONITORING, PHYSIOLOGIC; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; SEIZURES; XENON;

EID: 80052548876     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.119     Document Type: Review

References (105)

1. Hintz, S. R., Kendrick, D. E., Vohr, B. R., Poole, W. K. & Higgins, R. D. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999 Pediatrics 115, 1645-1651 (2005). (Pubitemid 43843175)
2. Clark, S. L. & Hankins, G. D. Temporal and demographic trends in cerebral palsy-fact and fiction. Am. J. Obstet. Gynecol. 188, 628-633 (2003). (Pubitemid 36332425)
3. Miller, S. P. & Ferriero, D. M. From selective vulnerability to connectivity: insights from newborn brain imaging. Trends Neurosci. 32, 496-505 (2009).
4. Back, S. A., Riddle, A. & McClure, M. M. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 38, 724-730 (2007). (Pubitemid 46184249)
5. Whitelaw, A. et al. Randomized clinical trial of prevention of hydrocephalus after intraventricular hemorrhage in preterm infants: brain-washing versus tapping fluid. Pediatrics 119, e1071-e1078 (2007). (Pubitemid 46715644)
6. Edwards, A. D. et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340, c363 (2010).
7. Perlman, J. M. et al. Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 122, S516-S538 (2010).
8. Azzopardi, D. Clinical management of the baby with hypoxic ischaemic encephalopathy. Early Hum. Dev. 86, 345-350 (2010).
9. Stola, A. & Perlman, J. Post-resuscitation strategies to avoid ongoing injury following intrapartum hypoxia-ischemia. Semin. Fetal Neonatal Med. 13, 424-431 (2008).
10. Gonzalez, F. F., Fang, A. & Ferriero, D. M. Is erythropoietin the answer? Pediatr. Res. 69, 2-3 (2011).
11. Chang, Y. S. et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr. Res. 58, 106-111 (2005). (Pubitemid 40967438)
12. Gonzalez, F. F. et al. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev. Neurosci. 31, 403-411 (2009).
13. Wen, T. C. et al. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 139, 803-811 (2006).
14. Sun, Y., Calvert, J. W. & Zhang, J. H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36, 1672-1678 (2005). (Pubitemid 41098760)
15. Osredkar, D., Sall, J. W., Bickler, P. E. & Ferriero, D. M. Erythropoietin promotes hippocampal neurogenesis in in-vitro models of neonatal stroke. Neurobiol. Dis. 38, 259-265 (2010).
16. Aher, S. & Ohlsson, A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews, Issue 3 Art. No.: CD004868 doi:10.1002/ 14651858CD004868pub2 (2006).
17. Juul, S. E. et al. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122, 383-391 (2008).
18. Elmahdy, H. et al. Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 125, e1135-e1142 (2010).
19. Zhu, C. et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124, e218-e226 (2009).
20. Faulkner, S. et al. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann. Neurol. doi:10.1002/ana.22387
21. Ma, J. & Zhang, G. Y. Lithium reduced N-methyl-d-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci. Lett. 348, 185-189 (2003). (Pubitemid 36980663)
22. Dinse, A. et al. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br. J. Anaesth. 94, 479-485 (2005).
23. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 65, 443-452 (2004). (Pubitemid 38134273)
24. Ma, D. et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann. Neurol. 58, 182-193 (2005). (Pubitemid 41098876)
25. Hobbs, C. et al. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 39, 1307-1313 (2008). (Pubitemid 351440706)
26. Neuroprotective effects of hypothermia combined with inhaled xenon following perinatal asphyxia (TOBYXe).ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/results/NCT00934700 (2009).
27. Jatana, M., Singh, I., Singh, A. K. & Jenkins, D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 59, 684-689 (2006). (Pubitemid 43740011)
28. Husson, I. et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann. Neurol. 51, 82-92 (2002). (Pubitemid 34027980)
29. Welin, A. K. et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 61, 153-158 (2007).
30. Hutton, L. C., Abbass, M., Dickinson, H., Ireland, Z. & Walker, D. W. Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus).Dev. Neurosci. 31, 437-451 (2009).
31. Bouslama, M. et al. Melatonin prevents learning disorders in brain-lesioned newborn mice. Neuroscience 150, 712-719 (2007). (Pubitemid 350214500)
32. Olivier, P. et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS ONE 4, e7218 (2009).
33. Kelen, D. & Robertson, N. J. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum. Dev. 86, 369-377 (2010).
34. Lynch, J. K. Epidemiology and classification of perinatal stroke. Semin. Fetal Neonatal Med. 14, 245-249 (2009).
35. Kersbergen, K. J. et al. Anticoagulation therapy and imaging in neonates with a unilateral thalamic hemorrhage due to cerebral sinovenous thrombosis. Stroke 40, 2754-2760 (2009).
36. Brouwer, M. J. et al. Ultrasound measurements of the lateral ventricles in neonates: why, how and when? A systematic review. Acta Paediatr. 99, 1298-1306 (2010).
37. Gonzalez, F. F. & Ferriero, D. M. Neuroprotection in the newborn infant. Clin. Perinatol. 36, 859-880 (2009).
38. Miller, S. P. et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 58, 542-548 (2002). (Pubitemid 34164934)
39. Bartha, A. I. et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr. Neurol. 37, 85-90 (2007). (Pubitemid 47187647)
40. Bittigau, P. et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl Acad. Sci. 99, 15089-15094 (2002). (Pubitemid 35334614)
41. Painter, M. J. et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N. Engl. J. Med. 341, 485-489 (1999). (Pubitemid 29372888)
42. Barks, J. D., Liu, Y. Q., Shangguan, Y. & Silverstein, F. S. Phenobarbital augments hypothermic neuroprotection. Pediatr. Res. 67, 532-537 (2010).
43. Meyn, D. F. Jr, Ness, J., Ambalavanan, N. & Carlo, W. A. Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy. J. Pediatr. 157, 334-336 (2010).
44. Sarkar, S. et al. Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy? J. Perinatol. doi:jp.10.1038201141
45. Liu, Y., Barks, J. D., Xu, G. & Silverstein, F. S. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35, 1460-1465 (2004). (Pubitemid 38697476)
46. Herrero, A. I., Del Olmo, N., Gonzalez-Escalada, J. R. & Solis, J. M. Two new actions of topiramate: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance. Neuropharmacology 42, 210-220 (2002). (Pubitemid 34137024)
47. Filippi, L. et al. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia 50, 2355-2361 (2009).
48. Cilio, M. R. & Ferriero, D. M. Synergistic neuroprotective therapies with hypothermia. Semin. Fetal Neonatal Med. 15, 293-298 (2010).
49. Kim, J. S., Kondratyev, A., Tomita, Y. & Gale, K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 48 (Suppl. 5), 19-26 (2007). (Pubitemid 47512198)
50. Maynard, D., Prior, P. F. & Scott, D. F. A continuous monitoring device for cerebral activity. Electroencephalogr. Clin. Neurophysiol. 27, 672-673 (1969).
51. Bjerre, I., Hellstrom-Westas, L., Rosen, I. & Svenningsen, N. Monitoring of cerebral function after severe asphyxia in infancy. Arch. Dis. Child. 58, 997-1002 (1983). (Pubitemid 14215841)
52. Hellstrom-Westas, L. & Rosen, I. Continuous brain-function monitoring: state of the art in clinical practice. Semin. Fetal Neonatal Med. 11, 503-511 (2006). (Pubitemid 44666598)
53. Holmes, G. et al. Prognostic value of the electroencephalogram in neonatal asphyxia. Electroencephalogr. Clin. Neurophysiol. 53, 60-72 (1982). (Pubitemid 12166227)
54. Biagioni, E. et al. Combined use of electroencephalogram and magnetic resonance imaging in full-term neonates with acute encephalopathy. Pediatrics 107, 461-468 (2001). (Pubitemid 32183177)
55. Hellstrom-Westas, L., Rosen, I. & Svenningsen, N. W. Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants. Arch. Dis. Child. Fetal Neonatal Ed. 72, F34-F38 (1995).
56. Toet, M. C., Hellstrom-Westas, L., Groenendaal, F., Eken, P. & de Vries, L. S. Amplitude integrated EEG 3 and 6 hours after birth in full term neonates with hypoxic-ischaemic encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 81, F19-F23 (1999). (Pubitemid 29307424)
57. van Rooij, L. G. et al. Recovery of amplitude integrated electroencephalographic background patterns within 24 hours of perinatal asphyxia. Arch. Dis. Child. Fetal Neonatal Ed. 90, F245-F251 (2005). (Pubitemid 40593455)
58. Osredkar, D. et al. Sleep-wake cycling on amplitude-integrated electroencephalography in term newborns with hypoxic-ischemic encephalopathy. Pediatrics 115, 327-332 (2005). (Pubitemid 43193814)
59. Thoresen, M., Hellstrom-Westas, L., Liu, X. & de Vries, L. S. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 126, e131-e139 (2010).
60. Nash, K. B. et al. Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology 76, 556-562 (2011).
61. Gunn, A. J. et al. Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J. Pediatr. 152, 55-58, 58 e51 (2008).
62. Toet, M. C., Lemmers, P. M., van Schelven, L. J. & van Bel, F. Cerebral oxygenation and electrical activity after birth asphyxia: their relation to outcome. Pediatrics 117, 333-339 (2006). (Pubitemid 46071596)
63. Malone, A. et al. Interobserver agreement in neonatal seizure identification. Epilepsia 50, 2097-2101 (2009).
64. Jensen, F. E. Neonatal seizures: an update on mechanisms and management. Clin. Perinatol 36, 881-900, vii (2009).
65. Holmes, G. L. & Ben-Ari, Y. Seizures in the developing brain: perhaps not so benign after all. Neuron 21, 1231-1234 (1998). (Pubitemid 29022525)
66. Holmes, G. L. & Ben-Ari, Y. The neurobiology and consequences of epilepsy in the developing brain. Pediatr. Res. 49, 320-325 (2001). (Pubitemid 32205229)
67. van Rooij, L. G. et al. Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial. Pediatrics 125, e358-e366 (2010).
68. Garfinkle, J. & Shevell, M. I. Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr. Neurol. 44, 88-96 (2011).
69. Bjorkman, S. T., Miller, S. M., Rose, S. E., Burke, C. & Colditz, P. B. Seizures are associated with brain injury severity in a neonatal model of hypoxia-ischemia. Neuroscience 166, 157-167 (2010).
70. Glass, H. C. et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J. Pediatr. 155, 318-323 (2009).
71. van Wezel-Meijler, G., Steggerda, S. J. & Leijser, L. M. Cranial ultrasonography in neonates: role and limitations. Semin. Perinatol 34, 28-38 (2010).
72. El-Dib, M., Massaro, A. N., Bulas, D. & Aly, H. Neuroimaging and neurodevelopmental outcome of premature infants. Am. J. Perinatol 27, 803-818 (2010).
73. van Wezel-Meijler, G. et al. Magnetic resonance imaging of the brain in newborn infants: practical aspects. Early Hum. Dev. 85, 85-92 (2009).
74. Dumoulin, C. L. et al. Magnetic resonance imaging compatible neonate incubator. Magn. Reson. Engineering 15, 117-128 (2002).
75. Mathur, A. M., Neil, J. J., McKinstry, R. C. & Inder, T. E. Transport, monitoring, and successful brain MR imaging in unsedated neonates. Pediatr. Radiol. 38, 260-264 (2008).
76. Rutherford, M. A. et al. Magnetic resonance imaging of white matter diseases of prematurity. Neuroradiology 52, 505-521 (2010).
77. Shah, D. K. et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J. Pediatr. 153, 170-175 (2008).
78. Glass, H. C. et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 122, 299-305 (2008).
79. Anjari, M. et al. The association of lung disease with cerebral white matter abnormalities in preterm infants. Pediatrics 124, 268-276 (2009).
80. Bonifacio, S. L. et al. Extreme premature birth is not associated with impaired development of brain microstructure. J. Pediatr. 157, 726-732e1 (2010).
81. Schmidt, B. et al. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 357, 1893-1902 (2007). (Pubitemid 350074685)
82. Doyle, L. W. et al. Caffeine and brain development in very preterm infants. Ann. Neurol. 68, 734-742 (2010).
83. Thayyil, S. et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 125, e382-e395 (2010).
84. Azzopardi, D. & Edwards, A. D. Magnetic resonance biomarkers of neuroprotective effects in infants with hypoxic ischemic encephalopathy. Semin. Fetal Neonatal Med. 15, 261-269 (2010).
85. Wartenberg, K. E. et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit. Care Med. 34, 617-623 (2006).
86. Diez-Tejedor, E. & Fuentes, B. Acute care in stroke: the importance of early intervention to achieve better brain protection. Cerebrovascular Diseases 17 (Suppl. 1), 130-137 (2004). (Pubitemid 38032531)
87. Mirski, M. A., Chang, C. W. & Cowan, R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J. Neurosurg. Anesthesiol. 13, 83-92 (2001). (Pubitemid 32244983)
88. Suarez, J. I. Outcome in neurocritical care: advances in monitoring and treatment and effect of a specialized neurocritical care team. Crit. Care Med. 34, S232-S238 (2006). (Pubitemid 44253710)
89. Varelas, P. N. et al. Impact of a neurointensivist on outcomes in patients with head trauma treated in a neurosciences intensive care unit. J. Neurosurg. 104, 713-719 (2006).
90. Diringer, M. N. & Edwards, D. F. Admission to a neurologic/ neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit. Care Med. 29, 635-640 (2001). (Pubitemid 32225309)
91. Solomon, R. A., Mayer, S. A. & Tarmey, J. J. Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality. Stroke 27, 13-17 (1996). (Pubitemid 26008288)
92. Berman, M. F., Solomon, R. A., Mayer, S. A., Johnston, S. C. & Yung, P. P. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34, 2200-2207 (2003).
93. Patel, H. C. et al. Specialist neurocritical care and outcome from head injury. Intensive Care Med. 28, 547-553 (2002). (Pubitemid 34594583)
94. Elf, K., Nilsson, P. & Enblad, P. Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care. Crit. Care Med. 30, 2129-2134 (2002).
95. Clayton, T. J., Nelson, R. J. & Manara, A. R. Reduction in mortality from severe head injury following introduction of a protocol for intensive care management. Br. J. Anaesth. 93, 761-767 (2004). (Pubitemid 39585604)
96. Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, Issue 4 Art. No.: CD000197 doi:10.1002/14651858CD000197pub2 (2007).
97. Glass, H. C. et al. Neurocritical care for neonates. Neurocrit. Care 12, 421-429 (2010).
98. McQuillen, P. S. & Miller, S. P. Congenital heart disease and brain development. Ann. NY Acad. Sci. 1184, 68-86 (2010).
99. Lester, B. M. et al. Infant neurobehavioral development. Semin. Perinatol. 35, 8-19 (2011).
100. Bustani, P. C. Developmental care: does it make a difference? Arch. Dis. Child. Fetal Neonatal Ed. 93, F317-F321 (2008). (Pubitemid 352039408)
101. Conde-Agudelo, A., Belizan, J. M. & Diaz-Rossello, J. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database of Systematic Reviews, Issue 3 Art. No.: CD002771 doi:10.1002/ 14651858CD002771pub2 (2011).
102. Maguire, C. M. et al. Effects of individualized developmental care in a randomized trial of preterm infants 32 weeks. Pediatrics 124, 1021-1030 (2009).
103. Peters, K. L. et al. Improvement of short- and long-term outcomes for very low birth weight infants: Edmonton NIDCAP trial. Pediatrics 124, 1009-1020 (2009).
104. McAnulty, G. B. et al. Effects of the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) at age 8 years: preliminary data. Clin. Pediatr. (Phila.) 49, 258-270 (2009).
105. Als, H. et al. Early experience alters brain function and structure. Pediatrics 113, 846-857 (2004). (Pubitemid 38437393)